These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 7122649)

  • 21. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
    Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
    Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slow-release 5-fluorouracil and triamcinolone reduces subglottic stenosis in a rabbit model.
    Ingrams DR; Ashton P; Dhingra J; Shah R; Shapshay SM
    Ann Otol Rhinol Laryngol; 2000 Apr; 109(4):422-4. PubMed ID: 10778898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative studies on grain size distribution and nature of particles of some corticoid crystal suspensions].
    Möllmann H; von Klot-Heydenfeldt B; Niemeyer DH; Alfes H
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):434-43. PubMed ID: 5046054
    [No Abstract]   [Full Text] [Related]  

  • 24. Fabrication of nanoparticles within polymeric pores for controlled release of drug.
    Asif M; Arayne MS; Sultana N; Hussain F
    Pak J Pharm Sci; 2006 Jan; 19(1):73-84. PubMed ID: 16632458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional versus novel conditions for the in vitro dissolution testing of parenteral slow release formulations: application to doxepin parenteral dosage forms.
    Gido C; Langguth P; Kreuter J; Winter G; Woog H; Mutschler E
    Pharmazie; 1993 Oct; 48(10):764-9. PubMed ID: 8265710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles.
    Giri S; Trewyn BG; Stellmaker MP; Lin VS
    Angew Chem Int Ed Engl; 2005 Aug; 44(32):5038-44. PubMed ID: 16038000
    [No Abstract]   [Full Text] [Related]  

  • 27. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A flexible drug delivery chip for the magnetically-controlled release of anti-epileptic drugs.
    Huang WC; Hu SH; Liu KH; Chen SY; Liu DM
    J Control Release; 2009 Nov; 139(3):221-8. PubMed ID: 19607866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Local atrophy after injection of a depot corticosteroid].
    Hørthe K
    Tidsskr Nor Laegeforen; 1984 Sep; 104(27):1929. PubMed ID: 6515616
    [No Abstract]   [Full Text] [Related]  

  • 30. [Local atrophy following injection of depot corticosteroid].
    Haye R; Kolbenstvedt A
    Tidsskr Nor Laegeforen; 1984 Aug; 104(23):1532-3. PubMed ID: 6484907
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of diclofenac sodium after intramuscular administration in combination with triamcinolone acetate.
    Derendorf H; Mullersman G; Barth J; Grüner A; Möllmann H
    Eur J Clin Pharmacol; 1986; 31(3):363-5. PubMed ID: 3792436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hoigné's syndrome-like side effects following intralesional injection of triamcinolone crystalline suspension].
    Müller E
    Arch Klin Exp Dermatol; 1970; 237(1):184. PubMed ID: 5417103
    [No Abstract]   [Full Text] [Related]  

  • 33. Intramuscular triamcinolone diacetate therapy of dermatoses: preliminary report.
    WEINER AL
    Antibiot Chemother (Northfield); 1962 Jun; 12():360-6. PubMed ID: 14005707
    [No Abstract]   [Full Text] [Related]  

  • 34. [Medicinal preparations of suprarenal gland hormones. V. Methods of preparing microcrystalline suspensions of testosterone injections].
    Nerlo H; Umer S; Gwizdz Z
    Acta Pol Pharm; 1978; 35(3):339-46. PubMed ID: 696367
    [No Abstract]   [Full Text] [Related]  

  • 35. Nanoparticles--a new colloidal drug delivery system.
    Marty JJ; Oppenheim RC; Speiser P
    Pharm Acta Helv; 1978; 53(1):17-23. PubMed ID: 643885
    [No Abstract]   [Full Text] [Related]  

  • 36. How I treat synovial cysts.
    Montgomery RM
    Postgrad Med; 1971 Jan; 49(1):231. PubMed ID: 5539677
    [No Abstract]   [Full Text] [Related]  

  • 37. Preparation of gelatin nanocapsules and their pharmaceutical characterization.
    Krause HJ; Rohdewald P
    Pharm Res; 1985 Sep; 2(5):239-43. PubMed ID: 24272844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Entrapping efficiency and drug release profile of an oil-in-water (o/w) emulsion formulation using a polydimethylsiloxane-coated glass bead assay.
    Minagawa T; Kohno Y; Suwa T; Tsuji A
    Pharm Res; 1994 Apr; 11(4):503-7. PubMed ID: 8058605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triamcinolone diacetate nanoparticles, a sustained release drug delivery system suitable for parenteral administration.
    El-Samaligy M; Rohdewald P
    Pharm Acta Helv; 1982; 57(7):201-4. PubMed ID: 7122649
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral bioavailability of triamcinolone tablets and a triamcinolone diacetate suspension.
    Hochhaus G; Pörtner M; Barth J; Möllmann H; Rohdewald P
    Pharm Res; 1990 May; 7(5):558-60. PubMed ID: 1973290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.